Drug
somapacitan-beco
Marketed as SOGROYA.
Generic name
somapacitan-beco
Brand names
SOGROYA
First FDA approval
2020-08-28
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761156 | SOGROYA | 2020-08-28 | NOVO NORDISK INC |
Manufacturers
NOVO NORDISK INC
Frequently asked questions
When was somapacitan-beco FDA approved?
Earliest FDA approval on record: 2020-08-28.
What brand names are sold as somapacitan-beco?
SOGROYA.
Sources
Appeal a somapacitan-beco denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com